Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 15, 2019 - Issue
Submit an article Journal homepage
210
Views
11
CrossRef citations to date
0
Altmetric
Review

Clinical evaluation of the safety, efficacy and tolerability of sarilumab in the treatment of moderate to severe rheumatoid arthritis

Eleftherios PelechasRheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece
,
Paraskevi V VoulgariRheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, GreeceORCID Iconhttps://orcid.org/0000-0002-5193-2284
ORCID Icon &
Alexandros A DrososRheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, GreeceCorrespondence[email protected]
Pages 1073-1079 | Published online: 04 Sep 2019

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Efstathia Davoutis, Chrysa Panou, Nikolina Stachika, Christina Dalla & Nikolaos Kokras. (2023) Drug-drug interactions between COVID-19 drug therapies and antidepressants. Expert Opinion on Drug Metabolism & Toxicology 0:0, pages 1-14.
Read now
Eleftherios Pelechas, Paraskevi V Voulgari & Alexandros A. Drosos. (2021) Preclinical discovery and development of adalimumab for the treatment of rheumatoid arthritis. Expert Opinion on Drug Discovery 16:3, pages 227-234.
Read now

Articles from other publishers (9)

Jin Li, Yun R. Li, Joseph T. Glessner, Jie Yang, Michael E. March, Charlly Kao, Courtney N. Vaccaro, Jonathan P. Bradfield, Junyi Li, Frank D. Mentch, Hui‐Qi Qu, Xiaohui Qi, Xiao Chang, Cuiping Hou, Debra J. Abrams, Haijun Qiu, Zhi Wei, John J. Connolly, Fengxiang Wang, James Snyder, Berit Flatø, Susan D. Thompson, Carl D. Langefeld, Benedicte A. Lie, Jane E. Munro, Carol Wise, Patrick M. A. Sleiman & Hakon Hakonarson. (2022) Identification of Novel Loci Shared by Juvenile Idiopathic Arthritis Subtypes Through Integrative Genetic Analysis. Arthritis & Rheumatology 74:8, pages 1420-1429.
Crossref
Wen-Jia Zhao, Jiang-Hong Deng & Cai-Feng Li. (2022) Research progress in drug therapy of juvenile idiopathic arthritis. World Journal of Pediatrics 18:6, pages 383-397.
Crossref
Grainne M Murray, Ethan S Sen & Athimalaipet V Ramanan. (2021) Advancing the treatment of juvenile idiopathic arthritis. The Lancet Rheumatology 3:4, pages e294-e305.
Crossref
Christoffer Mørk, Mette Y. Dam, Mikkel G. Callsen & Kresten K. Keller. (2020) The effect of a nurse-led prednisolone tapering regimen in polymyalgia rheumatica: a retrospective cohort study. Rheumatology International 41:3, pages 605-610.
Crossref
Rajashri R. Naik & Ashok K. Shakya. (2021) Therapeutic Strategies in the Management of COVID-19. Frontiers in Molecular Biosciences 7.
Crossref
Zunlian Wang, Min Huang, Bin Yu, Yilan Huang, Silin Zheng, Xuping Yang & Hong Ning. (2021) Comparison of the efficacy and safety indicators of DMARDs for rheumatoid arthritis. Medicine 100:29, pages e26524.
Crossref
Venkatesh Pooladanda, Sowjanya Thatikonda & Chandraiah Godugu. (2020) The current understanding and potential therapeutic options to combat COVID-19. Life Sciences 254, pages 117765.
Crossref
Pelechas Eleftherios & Karagianni Panagiota. (2020) Rheumatoid arthritis: Treatment evolution over the years. Open Journal of Pharmacology and Pharmacotherapeutics 5:1, pages 024-026.
Crossref
D. E. Karateev & E. L. Luchikhina. (2019) Inhibitor of biological effects of interleukin-6 sarilumab in treatment of rheumatoid arthritis. Medical Council:18, pages 85-91.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.